Emerging research highlights how vitamin D boosts immunity and reduces colorectal cancer (CRC) risk by regulating ...

T-cell activation involves two phases, enabling a more precise immune response. This insight may boost cancer immunotherapy effectiveness. A research team led by Wolfgang Kastenmüller and Georg ...

In certain cancers, QRICH1 could be used to increase T-cell activation to fight and kill off cancer cells more effectively. In autoimmune diseases and certain blood cancers, including leukemia and ...

NOVEL lymph-node-inspired hydrogels enhance CAR T cell activation and proliferation by 50%, offering a more efficient and ...

A team from the Max Planck Research Group for Systems Immunology at the University of Würzburg has identified a previously ...

The research teams led by Wolfgang Kastenmüller and Georg Gasteiger utilized advanced microscopy techniques to investigate ...

The research groups led by Wolfgang Kastenmüller and Georg Gasteiger employed innovative microscopy techniques to observe how ...

CURE provides access to the cancer news, latest oncology research & expert insights that serve as a guide to every stage of ...

AP402 targets p95HER2, a truncated form of HER2 present in 30-40% of HER2-positive cancers, which is associated with exceptionally poor prognosis, and not addressable by conventional anti-HER2 ...

AP Biosciences, a clinical-stage biopharmaceutical company dedicated to transforming cancer therapy through innovative bispecific antibodies, today announced that it will present a preclinical ...